Tweet
The Lancet Infect Dis. Applying lessons from SARS to a newly identified coronavirus
[Source: The Lancet Infectious Diseases, full text: (LINK). Extract, edited.]
------
The Lancet Infectious Diseases, Early Online Publication, 21 March 2013
doi:10.1016/S1473-3099(13)70082-3
Applying lessons from SARS to a newly identified coronavirus
Original Text
Brian McCloskey a, Alimuddin Zumla b, Gwen Stephens d, David L Heymann c, Ziad A Memish d e
Human infection with a newly identified novel coronavirus has rapidly focused global attention on risk assessment 1?6 because its epidemic potential is not known. First detected in September, 2012, in a patient who had died of an acute respiratory illness in Saudi Arabia, 4 it was soon confirmed in a Qatari patient with a similar illness in London, UK. These cases triggered collaborations between the Kingdom of Saudi Arabia Ministry of Health (KSA-MoH), Qatar, and other global partners. The immediat ...
__________
a WHO Collaborating Centre on Mass Gatherings and Health Protection Agency, UK; b Division of Infection and Immunity, University College London, London, UK; c Centre on Global Health Security Chatham House, and London School of Hygiene and Tropical Medicine, London, UK; d WHO Collaborating Centre for Mass Gathering Medicine, Ministry of Health, Saudi Arabia; e Al-Faisal University, Riyadh, Saudi Arabia
-doi:10.1016/S1473-3099(13)70082-3
Applying lessons from SARS to a newly identified coronavirus
Original Text
Brian McCloskey a, Alimuddin Zumla b, Gwen Stephens d, David L Heymann c, Ziad A Memish d e
Human infection with a newly identified novel coronavirus has rapidly focused global attention on risk assessment 1?6 because its epidemic potential is not known. First detected in September, 2012, in a patient who had died of an acute respiratory illness in Saudi Arabia, 4 it was soon confirmed in a Qatari patient with a similar illness in London, UK. These cases triggered collaborations between the Kingdom of Saudi Arabia Ministry of Health (KSA-MoH), Qatar, and other global partners. The immediat ...
__________
a WHO Collaborating Centre on Mass Gatherings and Health Protection Agency, UK; b Division of Infection and Immunity, University College London, London, UK; c Centre on Global Health Security Chatham House, and London School of Hygiene and Tropical Medicine, London, UK; d WHO Collaborating Centre for Mass Gathering Medicine, Ministry of Health, Saudi Arabia; e Al-Faisal University, Riyadh, Saudi Arabia
------